# Dexmedetomidine Versus Ketofol for Moderate Sedation in Endoscopic Retrograde Cholangiopancreatography

> **NCT06212401** · PHASE4 · COMPLETED · sponsor: **Sindh Institute of Urology and Transplantation** · enrollment: 62 (actual)

## Conditions studied

- Sedation

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Ketofole

## Key facts

- **NCT ID:** NCT06212401
- **Lead sponsor:** Sindh Institute of Urology and Transplantation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06212401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06212401, "Dexmedetomidine Versus Ketofol for Moderate Sedation in Endoscopic Retrograde Cholangiopancreatography". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06212401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*